We are live on ! Find out more
LAB icon

Standard BioTools
LAB

138 hedge funds and large institutions have $269M invested in Standard BioTools in 2021 Q1 according to their latest regulatory filings, with 27 funds opening new positions, 43 increasing their positions, 41 reducing their positions, and 34 closing their positions.

New
Increased
Maintained
Reduced
Closed

5% more repeat investments, than reductions

Existing positions increased: 43 | Existing positions reduced: 41

5% less funds holding

Funds holding: 145 → 138 (-7)

8.48% less ownership

Funds ownership: 88.1% → 79.63% (-8.5%)

21% less first-time investments, than exits

New positions opened: 27 | Existing positions closed: 34

25% less call options, than puts

Call options by funds: $4.53M | Put options by funds: $6.01M

31% less capital invested

Capital invested by funds: $391M → $269M (-$123M)

33% less funds holding in top 10

Funds holding in top 10: 3 → 2 (-1)

Holders
138
Holders Change
-7
Holders Change %
-4.83%
% of All Funds
2.42%
Holding in Top 10
2
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-33.33%
% of All Funds
0.04%
New
27
Increased
43
Reduced
41
Closed
34
Calls
$4.53M
Puts
$6.01M
Net Calls
-$1.47M
Net Calls Change
-$4.11M

Top Buyers

1
ICM
Indaba Capital Management
California
+$10.5M
2
NIM
Needham Investment Management
New York
+$6.33M
3
CPA
Cowen Prime Advisors
New York
+$5.4M
4
SC
Samjo Capital
New York
+$4.48M
5
O
OrbiMed
New York
+$3.88M

Top Sellers

1
AI
Atom Investors
Texas
-$17.5M
2
Fidelity Investments
Fidelity Investments
Massachusetts
-$16.2M
3
ACM
Asymmetry Capital Management
California
-$9.27M
4
Marshall Wace
Marshall Wace
United Kingdom
-$7.67M
5
GCM
Glenview Capital Management
New York
-$4.86M
Name Holding Trade Value Shares
Change 		Change in
Stake
Alyeska Investment Group
26
Alyeska Investment Group
Illinois
$2.33M -$2.03M -370,103 -42%
Susquehanna International Group
27
Susquehanna International Group
Pennsylvania
$2.23M +$547K +99,572 +25%
PP
28
PDT Partners
New York
$2.19M +$2.24M +408,243 +542%
BFM
29
Boothbay Fund Management
New York
$2.1M +$2.55M +465,020 New
CS
30
Candriam SCA
Luxembourg
$1.83M – – –
Goldman Sachs
31
Goldman Sachs
New York
$1.57M -$868K -158,025 -31%
Bank of New York Mellon
32
Bank of New York Mellon
New York
$1.4M -$851K -154,868 -33%
Two Sigma Investments
33
Two Sigma Investments
New York
$1.2M -$1.79M -325,869 -55%
Principal Financial Group
34
Principal Financial Group
Iowa
$1.06M +$98.2K +17,870 +8%
SW
35
SkyOak Wealth
Michigan
$918K +$1.02M +185,806 New
AQR Capital Management
36
AQR Capital Management
Connecticut
$896K -$665K -121,031 -38%
CAM
37
Connacht Asset Management
New York
$860K -$270K -49,161 -21%
AC
38
Alexandria Capital
Virginia
$853K – – –
Charles Schwab
39
Charles Schwab
California
$840K +$23.4K +4,266 +2%
Jennison Associates
40
Jennison Associates
New York
$775K +$132K +23,989 +16%
Swiss National Bank
41
Swiss National Bank
Switzerland
$765K +$44.5K +8,100 +5%
Connor, Clark & Lunn Investment Management (CC&L)
42
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$676K -$790K -143,742 -49%
HSA
43
Hussman Strategic Advisors
Maryland
$651K -$330K -60,000 -29%
California Public Employees Retirement System
44
California Public Employees Retirement System
California
$647K -$73.6K -13,407 -9%
CM
45
Caption Management
Oklahoma
$562K +$448K +81,633 +190%
IP
46
Intellectus Partners
California
$528K – – –
Citadel Advisors
47
Citadel Advisors
Florida
$527K +$308K +56,162 +93%
SM
48
SG3 Management
Puerto Rico
$520K +$632K +115,000 New
RhumbLine Advisers
49
RhumbLine Advisers
Massachusetts
$512K -$23.4K -4,260 -4%
EGM
50
Engineers Gate Manager
New York
$507K +$554K +100,900 +893%
1
2
3 4 5

LAB Hedge Fund Activity: Q1 2021 in Review

138 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in Standard BioTools (LAB) for Q1 2021, worth a combined $269M — down 31% from $391M a quarter earlier.

Sellers outnumbered buyers: 34 funds closed out of LAB and 27 opened new positions — a net loss of 7 holders — while 41 trimmed existing stakes and 43 added.

The largest buyer was Indaba Capital Management, adding an estimated $10.5M. The largest seller was Atom Investors, exiting entirely with an estimated $17.5M sold.

  • 138 institutional investors held Standard BioTools (LAB) as of Q1 2021, down from 145 in Q4 2020.
  • Funds reported $269M of Standard BioTools stock for Q1 2021, down 31% quarter-over-quarter.
  • 27 funds opened new Standard BioTools positions in Q1 2021 and 34 closed out, a net change of -7 holders.
  • The largest Standard BioTools buyer in Q1 2021 was Indaba Capital Management, an estimated $10.5M added.
  • The largest Standard BioTools seller in Q1 2021 was Atom Investors, an estimated $17.5M sold.

Based on aggregated 13F filings for Q1 2021.